Company Limited and its subsidiaries (“the Company”) would like to clarify herewith the operating result for Quarter 3 Ended 30 September 2019 as follows:- Financial Position As at 30 September 2019 total

obtained Objectives : To support business expansion of subsidiary company which has a high growth retail finance business in Cambodia and also comply with the regulations of National Bank of Cambodia. The

year of 2019 and more efficient cost management that caused selling and administrative expense to decrease by 1.5% from the year of 2018. For the branches expansion in the year of 2019, the company

Exchange of Thailand The Board of Directors’ Meeting of Ladprao General Hospital Public Company Limited (the “Company”), No.4/2020, held on August 14, 2020, has approved the financial statements of the

www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the

was 6.4bn, -2.1% YoY, and -9.5% QoQ Excluding one-time items and FX loss, normalized NPAT was 6.7bn, +0.9% and -0.7% QoQ Continuous 5G subscriber scale expansion and maintain a leading position in 5G

changing environment. With respect to expansion of investor base, the SEC agreed with ASCO in that ?introducing agent? service will be provided. The service provider will not be limited to financial

enter an expansion phase again. Golden Lime Public Company Limited 4 MANAGEMENT DISCUSSION AND ANALYSIS FOR PERIOD ENDED 30 JUNE 2020 3. Financial highlights (based on Thai FRS) Q2 2020 Income statement

1 Zen Corporation Group Public Company Limited 662 Soi Onnuch 17, Suanluang, Bangkok 10250 THAILAND. Tel: 02-0195000 11 November 2019 No. ZEN 2562-023 Subject Management Discussion and Analysis for

• There are currently 4 main projects that are under construction including: - Xayaburi Power Company Limited (with 99.4% construction progress) - Rayong Central Utility Plants Expansion Phase (CUP-4) (98.2